CORONAVIRUS (COVID-19) VACCINATION: SCIENTIFIC FACTS. THE GREEK REPORT
DOI:
https://doi.org/10.46827/ejphs.v6i2.151Keywords:
Coronavirus (COVID-19), vaccination, Greek, scientific factsAbstract
Since its emergence in Wuhan, China, in late 2019, COVID-19 has rapidly become a pandemic spreading to all countries worldwide and demanding urgent healthcare response. The social and economic impact of the COVID-19 pandemic has taken variable shapes and forms regarding its effect on communities and decision-making, while the major risks probably arise not from the virus itself but from the indirect effects of the control measures and the societal activities. Owing to experiences from previous pandemics generating global health crises such as the HIV5 pandemic (1980), the Spanish flu (1918) and the 2009 flu the healthcare community had now more scientific facts to handle the COVID-19 pandemic as shown by the faster time it took for the development and licensing of the vaccines from the time the first case was identified. Although the control and vaccination strategies against the COVID-19 virus are still controversial issues as they have the potential to multiply the impact of the pandemic, this report aims to provide a timely review on the facts regarding the measures and the policy-making in Greece and how they affected the citizens in a socioeconomic and psychological context.
References
Alcoforado, F. (2020). The world after coronavirus. Available at: https://www.academia.edu/42549068/ (Last accessed on: April 10, 2023).
Allen, J. D., Feng, W., Corlin, L., Porteny, T., Acevedo, A., Schildkraut, D., King, E., Ladin, K., Fu, Q., & Stopka, T. J. (2021). Why are some people reluctant to be vaccinated for COVID-19? A cross-sectional survey among U.S. Adults in May-June 2020. Preventive Medicine Reports, 24. https://doi.org/10.1016/j.pmedr.2021.101494
Alexopoulos P., et al. (2022). Hospital workforce mental reaction to the pandemic in a low COVID-19 burden setting: a cross-sectional clinical study. European Archives of Psychiatry and Clinical Neuroscience 272:95105 https://doi.org/10.1007/s00406-021-01262-y
Australian Government. (2022) Health.gov.au. (2022). Available at : https://www.health.gov.au/sites/default/files/documents/2021/03/covid-19-vaccination-astrazeneca-covid-19-information-on-covid-19-astrazeneca-vaccine_4.docx (Last accessed on: May 6, 2023).
Bootsma, Martin C. J.; Ferguson, Neil M. (2007). The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proceedings of the National Academy of Sciences of the United States of America 104 (18): 7588–7593. doi:10.1073/pnas.0611071104
Bowen, R. A. R. (2020). Ethical and organizational considerations for mandatory COVID-19 vaccination of health care workers: A clinical laboratorian’s perspective. Clinica Chimica Acta, 510(510), 421–422. https://doi.org/10.1016/j.cca.2020.08.003
Butler, D. (May 2009). How severe will the flu outbreak be?. Nature. 459 (7243): 14–15. doi:10.1038/459014
Chaussois, R. The Spanish flu of 1918-1919, Pictured Story, Issue: 17 (Νovember 1969).
Delinasios, G. J., Fragkou, P. C., Gkirmpa A. M., Tsangkaris, G., Hoffman, R. M., Anagnostopoulos, A. K., In Vivo, March 2021, 35 (2) 1285-1294; doi: https://doi.org/10.21873/invivo.12380
European Commission (2021a). Safe COVID-19 vaccines for Europeans. Available at: https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-covid19vaccines-europeans_el#---3 (Last accessed on: April 29, 2023).
European Immunization Information Portal (2021b). Mode of action of vaccines. Available at: https://vaccination-info.eu/el/stoiheia-shetika-me-ta-embolia/tropos-drasiston-embolion (Last accessed on: April 18, 2023).
European Medical Agency (2021a). Spikevax1 (mRNA vaccine COVID-19 [modified nucleosides]). Available at: https://www.ema.europa.eu/en/documents/overview/spikevaxpreviously-covid-19-vaccinemoderna-epar-medicine-overview_el.pdf (Last accessed on: April 29, 2023).
European Medical Agency (2021b). Appendix 1: Summary of its features product. Available at: https://www.ema.europa.eu/en/documents/productinformation/covid-19vaccine-janssen-epar-product-information_el.pdf (Last accessed on: May 3rd, 2023).
Kaplan J. E., Benson C., Holmes K. K., Brooks, J. T., Pau A., Masur H. (2009). Centers for Disease Control and Prevention (CDC). National Institutes of Health. HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4. [PubMed]
Karaivazoglou K., et al. (2021). Psychological distress in the Greek general population during the first COVID-19 lockdown. BJPsych Open. DOI: 10.1192/bjo.2021.17
Number of COVID-19 vaccine doses administered in Europe as of January 18, 2023, by country (per 100 population). Available at: https://www.statista.com/statistics/1196071/covid-19-vaccination-rate-in-europe-by-country/ (Last accessed on: May 25, 2023).
OECD (2020). A framework to guide an education response to the COVID-19 Pandemic of 2020. OECD Publishing (2021). Information about the AstraZeneca vaccine against COVID19. Available at: https://www.health.gov.au (Last accessed on: April 30, 2023).
Polack, F. P., Thomas, S. J., Kitchin, N., Absalom, J. et al. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine, 383: 2603-2615. DOI: 10.1056/NEJMoa2034577
Triantafyllidou, Μ. (2020). The COVID-19 pandemic and its impact on mental health. Rostrum of Asclepius, 19(4), 274–294. https://doi.org/10.5281/zenodo.4061809
World Health Organization. Greece. Available at: https://www.who.int/countries/grc/en/ (Last accessed on May 10, 2023).
Waymack J. R., Sundareshan, V. (2023). Acquired Immune Deficiency Syndrome. NCBI https://www.ncbi.nlm.nih.gov/books/NBK537293/
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
